Abstract
High hypoxia-inducible factor-2alpha (HIF-2alpha) protein levels predict poor outcome in neuroblastoma, and hypoxia dedifferentiates cultured neuroblastoma cells toward a neural crest-like phenotype. Here, we identify HIF-2alpha as a marker of normoxic neural crest-like neuroblastoma tumor-initiating/stem cells (TICs) isolated from patient bone marrows. Knockdown of HIF-2alpha reduced VEGF expression and induced partial sympathetic neuronal differentiation when these TICs were grown in vitro under stem cell-promoting conditions. Xenograft tumors of HIF-2alpha-silenced cells were widely necrotic, poorly vascularized, and resembled the bulk of tumor cells in clinical neuroblastomas by expressing additional sympathetic neuronal markers, whereas control tumors were immature, well-vascularized, and stroma-rich. Thus, HIF-2alpha maintains an undifferentiated state of neuroblastoma TICs. Because low differentiation is associated with poor outcome and angiogenesis is crucial for tumor growth, HIF-2alpha is an attractive target for neuroblastoma therapy.
Original language | English |
---|---|
Journal | Proceedings of the National Academy of Sciences of the United States of America |
Volume | 106 |
Issue number | 39 |
Pages (from-to) | 16805-10 |
Number of pages | 6 |
ISSN | 0027-8424 |
DOIs | |
Publication status | Published - 29 Sept 2009 |
Externally published | Yes |
Keywords
- Animals
- Basic Helix-Loop-Helix Transcription Factors/genetics
- Cell Differentiation
- Cell Hypoxia
- Cell Line, Tumor
- Down-Regulation
- Female
- Humans
- Mice
- Mice, Nude
- Neural Crest/metabolism
- Neuroblastoma/metabolism
- Vascular Endothelial Growth Factors/genetics